Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen T Holgate

Showing results (131-140 of 232) with videos related to

Pageof 24
Sort By:
Current Pharmaceutical Design|April 8, 2015
Efficacy of Andolast in Mild to Moderate Asthma: A Randomized, Controlled, Double-Blind Multicenter Study (The Andast Trial)Mario Malerba, Massimo D Amato, Alessandro Radaeli, et al.
Expert Reviews in Molecular Medicine|September 25, 2004
The discovery and role of ADAM33, a new candidate gene for asthmaJohn W Holloway, Donna E Davies, Robert Powell, et al.
Lancet (London, England)|March 19, 2002
Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort studyJonathan M Corne, Clare Marshall, Sandra Smith, et al.
Clinical Science (London, England : 1979)|December 23, 2009
A new look at the pathogenesis of asthmaStephen T Holgate, Hasan S Arshad, Graham C Roberts, et al.
The Journal of Allergy and Clinical Immunology|February 19, 2011
Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirusJulie A Cakebread, Yunhe Xu, Chris Grainge, et al.
Clinical Reviews in Allergy & Immunology|September 7, 2004
ADAM 33 and its association with airway remodeling and hyperresponsiveness in asthmaStephen T Holgate, Donna E Davies, Steuart Rorke, et al.
Particle and Fibre Toxicology|May 8, 2008
Diesel exhaust increases EGFR and phosphorylated C-terminal Tyr 1173 in the bronchial epitheliumJamshid Pourazar, Anders Blomberg, Frank J Kelly, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2006
Understanding the pathophysiology of severe asthma to generate new therapeutic opportunitiesStephen T Holgate, John Holloway, Susan Wilson, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2007
Effect of IL-13 receptor alpha2 levels on the biological activity of IL-13 variant R110QAllison-Lynn Andrews, Fabio Bucchieri, Kazuhiko Arima, et al.
Biochemical Society Transactions|July 21, 2009
Cytoplasmic tail of IL-13Ralpha2 regulates IL-4 signal transductionAllison-Lynn Andrews, Ida Karin Nordgren, Isabelle Kirby, et al.
Pageof 24

Showing results (131-140 of 232) with videos related to

Sort By:
Pageof 24
Current Pharmaceutical Design|April 8, 2015
Efficacy of Andolast in Mild to Moderate Asthma: A Randomized, Controlled, Double-Blind Multicenter Study (The Andast Trial)Mario Malerba, Massimo D Amato, Alessandro Radaeli, et al.
Expert Reviews in Molecular Medicine|September 25, 2004
The discovery and role of ADAM33, a new candidate gene for asthmaJohn W Holloway, Donna E Davies, Robert Powell, et al.
Lancet (London, England)|March 19, 2002
Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort studyJonathan M Corne, Clare Marshall, Sandra Smith, et al.
Clinical Science (London, England : 1979)|December 23, 2009
A new look at the pathogenesis of asthmaStephen T Holgate, Hasan S Arshad, Graham C Roberts, et al.
The Journal of Allergy and Clinical Immunology|February 19, 2011
Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirusJulie A Cakebread, Yunhe Xu, Chris Grainge, et al.
Clinical Reviews in Allergy & Immunology|September 7, 2004
ADAM 33 and its association with airway remodeling and hyperresponsiveness in asthmaStephen T Holgate, Donna E Davies, Steuart Rorke, et al.
Particle and Fibre Toxicology|May 8, 2008
Diesel exhaust increases EGFR and phosphorylated C-terminal Tyr 1173 in the bronchial epitheliumJamshid Pourazar, Anders Blomberg, Frank J Kelly, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2006
Understanding the pathophysiology of severe asthma to generate new therapeutic opportunitiesStephen T Holgate, John Holloway, Susan Wilson, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2007
Effect of IL-13 receptor alpha2 levels on the biological activity of IL-13 variant R110QAllison-Lynn Andrews, Fabio Bucchieri, Kazuhiko Arima, et al.
Biochemical Society Transactions|July 21, 2009
Cytoplasmic tail of IL-13Ralpha2 regulates IL-4 signal transductionAllison-Lynn Andrews, Ida Karin Nordgren, Isabelle Kirby, et al.
Pageof 24